Goro Yoshimura

1.0k total citations
55 papers, 837 citations indexed

About

Goro Yoshimura is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Goro Yoshimura has authored 55 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 16 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Goro Yoshimura's work include Breast Cancer Treatment Studies (11 papers), Cancer Diagnosis and Treatment (9 papers) and Breast Implant and Reconstruction (6 papers). Goro Yoshimura is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Cancer Diagnosis and Treatment (9 papers) and Breast Implant and Reconstruction (6 papers). Goro Yoshimura collaborates with scholars based in Japan, China and United States. Goro Yoshimura's co-authors include Qifeng Yang, Takaomi Suzuma, Teiji Umemura, Takeo Sakurai, Ichiro Mori, Misa Nakamura, Yasushi Nakamura, Kennichi Kakudo, Takeshi Tamaki and Yozo Kokawa and has published in prestigious journals such as Cancer, Cancer Research and Journal of neurosurgery.

In The Last Decade

Goro Yoshimura

52 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Goro Yoshimura Japan 17 395 274 251 202 165 55 837
Takaomi Suzuma Japan 17 358 0.9× 256 0.9× 306 1.2× 185 0.9× 160 1.0× 52 885
Teiji Umemura Japan 15 328 0.8× 227 0.8× 194 0.8× 177 0.9× 141 0.9× 37 684
B Gairard France 13 239 0.6× 160 0.6× 337 1.3× 213 1.1× 101 0.6× 32 644
Cristina Pons Spain 17 478 1.2× 303 1.1× 299 1.2× 114 0.6× 257 1.6× 24 1.2k
J Simony-Lafontaine France 12 427 1.1× 253 0.9× 474 1.9× 170 0.8× 136 0.8× 22 1.2k
Asta Varis Finland 8 467 1.2× 195 0.7× 204 0.8× 161 0.8× 128 0.8× 8 752
Dawn Steele United Kingdom 8 398 1.0× 256 0.9× 410 1.6× 95 0.5× 127 0.8× 8 761
B Devictor France 18 340 0.9× 156 0.6× 260 1.0× 62 0.3× 68 0.4× 39 773
Jeanie Wu Singapore 13 552 1.4× 258 0.9× 218 0.9× 81 0.4× 108 0.7× 14 904
Kathy A. Toy United States 17 666 1.7× 340 1.2× 358 1.4× 91 0.5× 77 0.5× 19 999

Countries citing papers authored by Goro Yoshimura

Since Specialization
Citations

This map shows the geographic impact of Goro Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goro Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goro Yoshimura more than expected).

Fields of papers citing papers by Goro Yoshimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goro Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goro Yoshimura. The network helps show where Goro Yoshimura may publish in the future.

Co-authorship network of co-authors of Goro Yoshimura

This figure shows the co-authorship network connecting the top 25 collaborators of Goro Yoshimura. A scholar is included among the top collaborators of Goro Yoshimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goro Yoshimura. Goro Yoshimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Qifeng, Yasushi Nakamura, Misa Nakamura, et al.. (2003). Loss of Msh2 is not associated with FHIT deletion in breast carcinomas.. PubMed. 22(5). 2591–5. 3 indexed citations
2.
Suzuma, Takaomi, Takeo Sakurai, Goro Yoshimura, et al.. (2003). Anastrozole-Induced remission of diaphragmatic paralysis from metastatic breast cancer treated with multiple prior therapies. Breast Cancer. 10(2). 153–156. 1 indexed citations
3.
Yang, Qifeng, Goro Yoshimura, Takeo Sakurai, & Kennichi Kakudo. (2002). The Fragile Histidine Triad gene and breast cancer.. PubMed. 8(7). RA140–4. 8 indexed citations
4.
Yang, Qifeng, Misa Nakamura, Yasushi Nakamura, et al.. (2002). Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.. PubMed. 8(9). 2890–3. 52 indexed citations
5.
Taniguchi, Emiko, Goro Yoshimura, Qifeng Yang, et al.. (2002). Cytologic grade of breast carcinoma.. The Journal of the Japanese Society of Clinical Cytology. 41(6). 388–393. 3 indexed citations
6.
Taniguchi, Emiko, Osamu Nunobiki, Ichiro Mori, et al.. (2002). Intraductal papilloma of the breast characterized by numerous isolated tumor cells. A case report.. The Journal of the Japanese Society of Clinical Cytology. 41(5). 357–359. 2 indexed citations
7.
Suzuma, Takaomi, Takeo Sakurai, Goro Yoshimura, et al.. (2002). MR-axillography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection. Breast Cancer. 9(1). 69–74. 7 indexed citations
8.
Yang, Qifeng, Goro Yoshimura, Ichiro Mori, Takeo Sakurai, & Kenji Kakudo. (2002). Chromosome 3p and breast cancer. Journal of Human Genetics. 47(9). 453–459. 35 indexed citations
9.
Tang, Weihua, Emiko Taniguchi, Xiaojuan Wang, et al.. (2002). Loss of Cell Cohesion in Breast Cytology as a Characteristic of Neuroendocrine Carcinoma. Acta Cytologica. 46(5). 835–840. 12 indexed citations
10.
Yang, Qifeng, Goro Yoshimura, Takaomi Suzuma, et al.. (2001). Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.. PubMed. 7(12). 3869–73. 27 indexed citations
11.
Yang, Qifeng, Mattia Barbareschi, Ichiro Mori, et al.. (2001). Prognostic value of thymidine phosphorylase expression in breast carcinoma. International Journal of Cancer. 97(4). 512–517. 34 indexed citations
12.
Suzuma, Takaomi, Takeo Sakurai, Goro Yoshimura, et al.. (2001). Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma. Anti-Cancer Drugs. 12(9). 731–734. 23 indexed citations
13.
Yang, Qifeng, Ichiro Mori, Liang Shan, et al.. (2001). Biallelic Inactivation of Retinoic Acid Receptor β2 Gene by Epigenetic Change in Breast Cancer. American Journal Of Pathology. 158(1). 299–303. 53 indexed citations
14.
Yang, Qifeng, Takeo Sakurai, Ichiro Mori, et al.. (2001). Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer. 92(1). 54–60. 77 indexed citations
15.
Yang, Qifeng, Goro Yoshimura, Takeo Sakurai, et al.. (2001). Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor β2 expression in breast carcinoma. Breast Cancer Research and Treatment. 70(1). 39–45. 10 indexed citations
16.
Yang, Qifeng, Takeo Sakurai, Liang Shan, et al.. (2000). Thymidine phosphorylase expression correlates with tumor differentiation and bcl-2 in invasive breast cancer. Breast Cancer. 7(3). 210–214. 5 indexed citations
17.
Yang, Qifeng, Takeo Sakurai, Goro Yoshimura, et al.. (2000). Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma. Breast Cancer Research and Treatment. 61(3). 211–216. 35 indexed citations
18.
Oura, Shoji, et al.. (1999). [Breast cancer with osteoblastic bone metastasis treated successfully with bisphosphonate: a case report].. PubMed. 26(11). 1651–5. 1 indexed citations
19.
Yang, Qifeng, Takeo Sakurai, Xuefeng Jing, et al.. (1999). Expression of Bcl‐2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma. Pathology International. 49(9). 775–780. 36 indexed citations
20.
Oura, Shoji, Takeo Sakurai, Goro Yoshimura, et al.. (1996). Relief of Severe Pain by Pamidronate in a Case of Terminal Lung Carcinoma.. Haigan. 36(4). 449–453. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takaomi Suzuma Breakdown of academic impact, for papers by Teiji Umemura Breakdown of academic impact, for papers by B Gairard Breakdown of academic impact, for papers by Cristina Pons Breakdown of academic impact, for papers by J Simony-Lafontaine Breakdown of academic impact, for papers by Asta Varis Breakdown of academic impact, for papers by Dawn Steele Breakdown of academic impact, for papers by B Devictor Breakdown of academic impact, for papers by Jeanie Wu Breakdown of academic impact, for papers by Kathy A. Toy
Rankless by CCL
2026